Welcome to our dedicated page for GENWORTH FINANCIAL SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GENWORTH FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GENWORTH FINANCIAL's regulatory disclosures and financial reporting.
Genworth Financial EVP & Chief Financial Officer Jerome T. Upton reported equity compensation transactions involving restricted stock units (RSUs) and common shares. On February 26, 2026, RSUs covering 43,431 units and 37,506 units were exercised and converted into the same number of shares of common stock at a stated price of $0.0000 per share.
In connection with these RSU vestings, the company withheld 11,548 shares and 10,415 shares of common stock at $8.62 per share to cover tax withholding obligations, described as tax-withholding dispositions rather than open-market sales. After these transactions, Upton directly owned 513,747 shares of Genworth Financial common stock.
Genworth Financial executive Samir B. Shah reported multiple equity award transactions involving Restricted Stock Units and Common Stock. On February 26, 2026, Restricted Stock Units vested and converted into 43,431 shares and 37,506 shares of Common Stock, at a 1:1 ratio.
To cover tax withholding on these vestings, the company withheld 15,683 shares and 13,544 shares of Common Stock at a price of $8.62 per share. After these exercises and tax-withholding dispositions, Shah directly owned 98,168 shares of Genworth Financial Common Stock.
Genworth Financial EVP & Chief Investment Officer Kelly A. Saltzgaber reported equity compensation activity involving restricted stock units and common shares of Genworth Financial Inc. (GNW).
On February 26, 2026, restricted stock units vested and converted to common stock, with 29,316 and 28,129 restricted stock units exercised and settled into an equal number of common shares on a 1:1 basis. Following these transactions, direct common stock ownership increased through these conversions.
On the same date, a total of 8,499 and 8,155 shares of common stock were disposed of at $8.62 per share in transactions coded "F". According to the footnotes, these were shares withheld by the company to satisfy tax withholding obligations related to the vesting restricted stock units, rather than open-market sales.
Genworth Financial EVP and General Counsel Gregory S. Karawan reported equity compensation activity tied to vested Restricted Stock Units on February 26, 2026. Restricted Stock Units convert into Common Stock on a 1:1 basis.
He acquired 27,144 shares of Common Stock and separately 25,316 shares of Common Stock through exercises or conversions of Restricted Stock Units. To cover tax withholding on these vestings, the company withheld 7,533 shares of Common Stock at $8.62 per share and an additional 7,026 shares at $8.62 per share, classified as dispositions for tax-withholding purposes rather than open-market sales.
After these transactions, he directly owned 355,717 shares of Genworth Financial Common Stock and indirectly held 4,736.201 shares through a 401(k) account.
Genworth Financial EVP and Chief Risk Officer Mark Blakeley Hodges reported multiple equity award transactions. On February 26, 2026, Restricted Stock Units vested and converted into Common Stock on a 1:1 basis, resulting in the acquisition of 21,716 and 18,753 shares of Common Stock at $0.00 per share through derivative exercises.
To cover tax withholding on these vested awards, the company withheld 6,537 and 5,645 shares of Common Stock at $8.62 per share as tax-withholding dispositions. After these transactions, Hodges directly owned 139,111 shares of Genworth Financial Common Stock, with an additional 4,530.741 shares held indirectly through a 401(k) plan.
Genworth Financial EVP and Chief HR Officer Melissa Hagerman reported equity award activity related to restricted stock units (RSUs). On February 26, 2026, RSUs vested and converted into Common Stock on a 1:1 basis, increasing her direct holdings.
To cover tax withholding on the vested RSUs, the company withheld shares of Common Stock at a price of $8.62 per share, recorded as tax-withholding dispositions rather than open-market sales. After these exercises, conversions, and withholdings, Hagerman continued to hold Common Stock directly.
Genworth Financial executive Jamala M. Arland, Pres. & CEO, U.S. Life Insurance, reported multiple equity award transactions. On February 26, 2026, 27,144 and 30,004 Restricted Stock Units vested and converted into an equal number of Genworth common shares on a 1:1 basis.
The Form 4 also shows dispositions of 8,171 and 9,032 common shares at $8.62 per share. Footnotes explain these were shares withheld by the company to satisfy tax withholding obligations upon RSU vesting, rather than open-market sales.
Genworth Financial outlines a diversified insurance platform built around three areas: Enact mortgage insurance, a Closed Block of legacy life, annuity and long-term care, and newer CareScout aging‑care businesses.
Enact, which remains majority‑owned and consolidated, focuses on U.S. private mortgage insurance and returned $407 million of capital to Genworth Holdings in 2025. Genworth is using these funds, alongside cash flow, to back growth and capital management, including a share repurchase program under which it has bought back $828 million of common stock since 2022, within a current authorization of up to $350 million.
CareScout is central to Genworth’s growth plans. CareScout Services is building a nationwide network of roughly 790 home‑care providers and added senior living reach through the October 2025 acquisition of Seniorly. CareScout Insurance launched a new individual long‑term care product, Care Assurance, available in 40 states by February 2026, with conservative pricing and access to CareScout’s quality network.
The Closed Block legacy subsidiaries no longer write new life, annuity or GLIC long‑term care policies, but continue servicing in‑force business and pursuing multi‑year in‑force rate actions. From 2012 to 2025, approved long‑term care rate increases and benefit reductions produced an estimated cumulative economic benefit of $34.5 billion on a net present value basis, supporting the aim of keeping these entities self‑sustaining.
Genworth emphasizes enterprise risk management, reinsurance and regulatory capital. Enact remains in compliance with PMIERs and state risk‑to‑capital limits, and its main subsidiary EMICO holds strong financial strength ratings, including an S&P rating of A- and Moody’s A2. Legacy life subsidiaries carry weaker A.M. Best ratings, but their risk‑based capital ratios exceed regulatory action thresholds. As of June 30, 2025, non‑affiliate holders owned common equity with an aggregate market value of about $3.1 billion, and as of February 24, 2026, there were 387,611,047 common shares outstanding.
Genworth Financial executive Taylor Morris, EVP & CIO, reported beneficial ownership of 64,563 Restricted Stock Units (RSUs) on an initial Form 3. These RSUs vest and convert into common stock in equal parts on May 21, 2026, May 21, 2027, and May 21, 2028, settling into common shares on a 1:1 basis.
Genworth Financial reported modest fourth-quarter 2025 results, with net income available to common stockholders of $2 million and adjusted operating income of $8 million, or $0.02 per diluted share. For full-year 2025, net income was $223 million and adjusted operating income was $144 million, or $0.35 per diluted share.
Results were driven by the Enact mortgage insurance segment, which delivered adjusted operating income of $146 million in the quarter, supported by low loss ratios and strong capital with an estimated PMIERs sufficiency ratio of 162%. The Closed Block segment posted a fourth-quarter adjusted operating loss of $114 million, including a $159 million loss in long-term care from higher claims and unfavorable assumption updates. Legacy insurance companies reported 2025 statutory pre-tax income of $71 million and an estimated RBC ratio of 300%, while holding-company cash and liquid assets ended the year at $234 million. Genworth also returned capital to shareholders, executing $94 million of share repurchases in the quarter and $245 million in 2025, totaling $790 million since program inception.